TY - JOUR
T1 - Multi-parametric thrombus profiling microfluidics detects intensified biomechanical thrombogenesis associated with hypertension and aging
AU - Din, Misbahud
AU - Paul, Souvik
AU - Ullah, Sana
AU - Yang, Haoyi
AU - Xu, Rong Guang
AU - Abidin, Nurul Aisha Zainal
AU - Sun, Allan
AU - Chen, Yiyao Catherine
AU - Gao, Rui
AU - Chowdhury, Bari
AU - Zhou, Fangyuan
AU - Rogers, Stephenie
AU - Miller, Mariel
AU - Biswas, Atreyee
AU - Hu, Liang
AU - Fan, Zhichao
AU - Zahner, Christopher
AU - Fan, Jing
AU - Chen, Zi
AU - Berman, Megan
AU - Xue, Lingzhou
AU - Ju, Lining Arnold
AU - Chen, Yunfeng
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Arterial thrombosis is a leading cause of death and disability worldwide with no effective bioassay for clinical prediction. As a symbolic feature of arterial thrombosis, severe stenosis in the blood vessel creates a high-shear, high-gradient flow environment that facilitates platelet aggregation towards vessel occlusion. Here, we present a thrombus profiling assay that monitors the multi-dimensional attributes of thrombi forming in such biomechanical conditions. Using this assay, we demonstrate that different receptor–ligand interactions contribute distinctively to the composition and activation status of the thrombus. Our investigation into hypertensive and older individuals reveals intensified biomechanical thrombogenesis and multi-dimensional thrombus profile abnormalities, endorsing the diagnostic potential of the assay. Furthermore, we identify the hyperactivity of GPIbα-integrin αIIbβ3 mechanosensing axis as a molecular mechanism that contributes to hypertension-associated arterial thrombosis. By studying drug-disease interactions and inter-individual variability, our work reveals a need for personalized anti-thrombotic drug selection that accommodates each patient’s pathological profile.
AB - Arterial thrombosis is a leading cause of death and disability worldwide with no effective bioassay for clinical prediction. As a symbolic feature of arterial thrombosis, severe stenosis in the blood vessel creates a high-shear, high-gradient flow environment that facilitates platelet aggregation towards vessel occlusion. Here, we present a thrombus profiling assay that monitors the multi-dimensional attributes of thrombi forming in such biomechanical conditions. Using this assay, we demonstrate that different receptor–ligand interactions contribute distinctively to the composition and activation status of the thrombus. Our investigation into hypertensive and older individuals reveals intensified biomechanical thrombogenesis and multi-dimensional thrombus profile abnormalities, endorsing the diagnostic potential of the assay. Furthermore, we identify the hyperactivity of GPIbα-integrin αIIbβ3 mechanosensing axis as a molecular mechanism that contributes to hypertension-associated arterial thrombosis. By studying drug-disease interactions and inter-individual variability, our work reveals a need for personalized anti-thrombotic drug selection that accommodates each patient’s pathological profile.
UR - http://www.scopus.com/inward/record.url?scp=85206963864&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85206963864&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-53069-9
DO - 10.1038/s41467-024-53069-9
M3 - Article
C2 - 39433750
AN - SCOPUS:85206963864
SN - 2041-1723
VL - 15
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 9067
ER -